OBJECTIVE: Recent research suggests that sleep disturbance, fatigue, and depressed mood form a symptom cluster in patients treated with chemotherapy. To date, however, no studies have examined lagged relationships among these symptoms during chemotherapy, a time when symptom variability is high. The aim of the current study was to examine lagged changes among daily symptoms during platinum-based chemotherapy. METHOD: Participants were 78 women with gynecologic cancer (mean age 63 years, SD = 11; 91% Caucasian, 97% non-Hispanic). Sleep disturbance was assessed via wrist actigraphy, whereas fatigue and depressed mood were assessed via daily diary in the week after participants' first chemotherapy infusion. Latent change score models (LCS) were used to examine lagged relationships between symptom pairs. RESULTS: High levels of sleep disturbance (i.e., minutes awake at night) were associated with earlier subsequent peaks in fatigue, and high levels of fatigue were associated with higher subsequent levels of depressed mood. CONCLUSIONS: These findings suggest that sleep disturbance, fatigue, and depressed mood occur in a cascade pattern during chemotherapy, in which increases in sleep disturbance contribute to fatigue, which, in turn, contributes to depressed mood. Interventions targeting symptoms early in the cascade, such as sleep disturbance, may provide benefits across multiple downstream symptoms. PsycINFO Database Record (c) 2013 APA, all rights reserved.
OBJECTIVE: Recent research suggests that sleep disturbance, fatigue, and depressed mood form a symptom cluster in patients treated with chemotherapy. To date, however, no studies have examined lagged relationships among these symptoms during chemotherapy, a time when symptom variability is high. The aim of the current study was to examine lagged changes among daily symptoms during platinum-based chemotherapy. METHOD:Participants were 78 women with gynecologic cancer (mean age 63 years, SD = 11; 91% Caucasian, 97% non-Hispanic). Sleep disturbance was assessed via wrist actigraphy, whereas fatigue and depressed mood were assessed via daily diary in the week after participants' first chemotherapy infusion. Latent change score models (LCS) were used to examine lagged relationships between symptom pairs. RESULTS: High levels of sleep disturbance (i.e., minutes awake at night) were associated with earlier subsequent peaks in fatigue, and high levels of fatigue were associated with higher subsequent levels of depressed mood. CONCLUSIONS: These findings suggest that sleep disturbance, fatigue, and depressed mood occur in a cascade pattern during chemotherapy, in which increases in sleep disturbance contribute to fatigue, which, in turn, contributes to depressed mood. Interventions targeting symptoms early in the cascade, such as sleep disturbance, may provide benefits across multiple downstream symptoms. PsycINFO Database Record (c) 2013 APA, all rights reserved.
Authors: John J McArdle; Fumiaki Hamgami; Kenneth Jones; Ferenc Jolesz; Ron Kikinis; Avron Spiro; Marilyn S Albert Journal: J Gerontol B Psychol Sci Soc Sci Date: 2004-11 Impact factor: 4.077
Authors: Joseph A Roscoe; Gary R Morrow; Jane T Hickok; Karen M Mustian; Jennifer J Griggs; Sara E Matteson; Peter Bushunow; Raman Qazi; Brian Smith Journal: Breast Cancer Res Treat Date: 2005-02 Impact factor: 4.872
Authors: Ann M Berger; Kimberly Wielgus; Melody Hertzog; Patricia Fischer; Lynne Farr Journal: Support Care Cancer Date: 2009-04-19 Impact factor: 3.603
Authors: Gary R Morrow; Jane T Hickok; Joseph A Roscoe; Richard F Raubertas; Paul L R Andrews; Patrick J Flynn; Harry E Hynes; Tarit K Banerjee; Jeffrey J Kirshner; David K King Journal: J Clin Oncol Date: 2003-12-15 Impact factor: 44.544
Authors: Eric S Zhou; Ann H Partridge; Karen L Syrjala; Alexis L Michaud; Christopher J Recklitis Journal: J Cancer Surviv Date: 2016-08-05 Impact factor: 4.442
Authors: Heather S L Jim; Bryan Evans; Jiyeon M Jeong; Brian D Gonzalez; Laura Johnston; Ashley M Nelson; Shelli Kesler; Kristin M Phillips; Anna Barata; Joseph Pidala; Oxana Palesh Journal: Biol Blood Marrow Transplant Date: 2014-04-18 Impact factor: 5.742
Authors: Laurence Leysen; Astrid Lahousse; Jo Nijs; Nele Adriaenssens; Olivier Mairesse; Sergei Ivakhnov; Thomas Bilterys; Eveline Van Looveren; Roselien Pas; David Beckwée Journal: Support Care Cancer Date: 2019-07-25 Impact factor: 3.603
Authors: Olga Husson; Floortje Mols; Lonneke van de Poll-Franse; Jolanda de Vries; Goof Schep; Melissa S Y Thong Journal: Support Care Cancer Date: 2015-01-06 Impact factor: 3.603
Authors: Emma B Holliday; Nathan F Dieckmann; Tasha L McDonald; Arthur Y Hung; Charles R Thomas; Lisa J Wood Journal: Radiother Oncol Date: 2015-12-29 Impact factor: 6.280